Waxman asks drug and device firms for CME reports

Share this article:
US Rep. Henry Waxman (D-CA), head of the House Committee on Oversight and Government Reform, asked several drug and device firms for reports relating to CME, as part of a new off-label marketing probe he opened.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions